Marina Basina, MD, a clinical professor in endocrinology, gerontology and metabolism at Stanford Medicine, noted that effectiveness "can be different due to the salt form differences." Formulation is a parallel issue
This is not because BPC-157 is weak
Anyone with a personal or family history of certain thyroid cancers, pancreatitis, or serious gastrointestinal disease sits outside the comfortable-experimentation zone these compounds occupy, since those conditions appeared in trial exclusion criteria for good reason
We also factored in broader cost of living expenses, including utilities, food, transportation, and healthcare
It can start accelerating today with Carbon World Health
20 doses 0.25mL = 5mL bacteriostatic water, creating a 20mg/mL solution